COVID-19
Regístrese
Annals of Hepatology
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Journal Information
Previous Issue | Next Issue
Issue
Vol. 11. Issue 1.
Pages 4-154 (January - February 2012)
Hepatology highlights
Hepatology Highlights
Zamil Karim, Yi-Tzu Nancy Fu, Eric M. Yoshida
Ann Hepatol. 2012;11:4-6
Open access
Concise review
Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis
Daniel S. Smyk, Eirini I. Rigopoulou, Luigi Muratori, Andrew K. Burroughs, Dimitrios P. Bogdanos
Ann Hepatol. 2012;11:7-14
Open access
Original article
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients(♦)
David R. Nelson, Stefan Zeuzem, Pietro Andreone, Peter Ferenci, Robert Herring, Donald M. Jensen, Patrick Marcellin, Paul J. Pockros, ... George Hill
Ann Hepatol. 2012;11:15-31
Open access
Intrafamilial seropositivity of hepatitis in patients with hepatitis B and C virus in hepatitis clinic in Hamadan, Iran
Mitra Ranjbar, Zahra Golzardi, Leila Sedigh, Shahbaz Nekoozadeh
Ann Hepatol. 2012;11:32-6
Open access
Serum lipids and chronic hepatitis C genotype 4: interaction and significance
Mahmoud A. Khattab, Mohammed Eslam, Mayada M. Aly, Mohammed Shatat, Yousef I. Mousa, Hesham Abd-Aalhalim, Hanan Aly, Yehia Shaker
Ann Hepatol. 2012;11:37-46
Open access
Prevalence and resistance pattern of genotype G and H in chronic hepatitis B and HIV co-infected patients in Mexico
José Antonio Mata Marín, Carla Ileana Arroyo Anduiza, Gloría Mara Calderón, Sergio Cazares Rodríguez, José Luis Fuentes Allen, Rafael Arias Flores, Jesús Gaytán Martínez
Ann Hepatol. 2012;11:47-51
Open access
Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial
Mario G. Pessôa, Hugo Cheinquer, Paulo R.L. Almeida, Giovanni F. Silva, Maria Patelli J.S. Lima, Raymundo Paraná, Marco A. Lacerda, Edison R. Parise, ... Fernando Tatsch
Ann Hepatol. 2012;11:52-61
Open access
Region 11 MELD Na exception prospective study
Robert A. Fisher, Douglas M. Heuman, Ann M. Harper, Martha K. Behnke, Alastair D. Smith, Mark W. Russo, Steven Zacks, John W. McGillicuddy, ... Satheesh Nair
Ann Hepatol. 2012;11:62-7
Open access
Serum homocysteine levels in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos, Jannis Kountouras, Kalliopi Patsiaoura, Evangelia Katsiki, Efthimia Zafeiriadou, Georgia Deretzi, Christos Zavos, Emmanouel Gavalas, ... Aristidis Slavakis
Ann Hepatol. 2012;11:68-76
Open access
Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin
Bryan D. Maliken, William F. Avrin, James E. Nelson, Jody Mooney, Sankaran Kumar, Kris V. Kowdley
Ann Hepatol. 2012;11:77-84
Open access
Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease
Norberto C. Chavez-Tapia, Ileana Mac Kinney-Novelo, Sergio E. Sifuentes-RenterÍa, Maximiliano Torres-Zavala, Gildardo Castro-Gastelum, Karla Sánchez-Lara, Carla Paulin-Saucedo, Misael Uribe, Nahum Méndez-Sánchez
Ann Hepatol. 2012;11:85-9
Open access
Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality
Grazielle Cerqueira de Carvalho, Catarina de Andrade Regis, Jamile Rosário Kalil, Liv Aparício Cerqueira, Daniel Silva Barbosa, Marina Pamponet Motta, Marília da Silva Nery, Maria Alice Pires Soares, ... Paulo Lisboa Bittencourt
Ann Hepatol. 2012;11:90-5
Open access
Hepatic dysfunction in children with tuberculosis on treatment with antituberculous therapy
Sasha Mansukhani, Ira Shah
Ann Hepatol. 2012;11:96-9
Open access
Effect of cirrhosis at baseline on the outcome of type 1 autoimmune hepatitis
Graciela Landeira, Silvia Morise, Eduardo Fassio, Margarita Ramonet, Estela Álvarez, Patricia Caglio, Cristina Longo, Nora DomÍnguez
Ann Hepatol. 2012;11:100-6
Open access
Amoebic liver abscess production by Entamoeba dispar
Silvio S. Dolabella, Jesús Serrano-Luna, Fernando Navarro-García, René Cerritos, Cecilia Ximénez, José Manuel Galván-Moroyoqui, Edward F. Silva, Víctor Tsutsumi, Mineko Shibayama
Ann Hepatol. 2012;11:107-17
Open access
Cytokines as important playmakers of experimental hepatocarcinogenesis confounded by diabetes
Nabil M. Abdel-Hamid, Maiiada H. Nazmy, Manal I. Abdel-Ghany, Walaa H. Nazmy
Ann Hepatol. 2012;11:118-27
Open access
Images in hepatology
Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy
Heriberto Medina-Franco, Daniel Zamora-Valdés, Ariadne Sánchez-Ramón, Gabriela Trejo-Gómez
Ann Hepatol. 2012;11:128-9
Open access
Case report
Abnormal liver function tests in a patient with myotonic dystrophy type 1
Maria Kalafateli, Christos Triantos, Athanasios Tsamandas, Gerasimos Kounadis, Chryssoula Labropoulou-Karatza
Ann Hepatol. 2012;11:130-3
Open access
An unusual cause of cancer mimicry following liver transplantation
Karim Qumosani, Natasha Chandok
Ann Hepatol. 2012;11:134-7
Open access
Acute liver failure due to non-exertional heatstroke after sauna
Elife Erarslan, ílhami Yüksel, Serap Haznedaroğ lu
Ann Hepatol. 2012;11:138-42
Open access
Letter to editor
Budd-Chiari syndrome after treatment with budesonide in a cirrhotic patient with autoimmune hepatitis
Ingmar Mederacke, Fabian Helfritz, Florian Puls, Kristina Imeen Ringe, Juergen Klempnauer, Michael P. Manns, Christian P. Strassburg
Ann Hepatol. 2012;11:143-4
Open access
Is it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors?
Suleyman Aydin
Ann Hepatol. 2012;11:145-6
Open access
Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease?
Gesira Florentino, Helma P. Cotrim, André Florentino, Consuelo Padilha, Manoel Medeiros-Neto, Gerson Bragagnoli, Paulo Schwingel
Ann Hepatol. 2012;11:147-9
Open access
Unusual cause of common bile duct dilatation in asymptomatic elderly patient: right hepatic artery syndrome
Adnan Tas, Seyfettin Koklu
Ann Hepatol. 2012;11:150-1
Open access
Liver news elsewhere
Intestinal nuclear bile acid receptor FXR and cholestasis
Jorge A. López-Velázquez, Ibrahim G. Castro-Torres, Vicente Sánchez-Valle, Nahum Méndez-Sánchez
Ann Hepatol. 2012;11:152-4
Open access

Subscribe to our newsletter

Publish in
Annals of Hepatology
Special content about COVID-19
Affiliated societies

 

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos